Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-21

Clinical Trial Update: Eltrombopag for Inherited Thrombocytopenias [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for eltrombopag in inherited platelet disorders (inherited thrombocytopenia).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eltrombopag (eltrombopag)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Inherited Platelet Disorder | Phase 2 | Status: COMPLETED